Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01727531 · ClinicalTrials.gov registry record · NA
IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy
A NA study, sponsored by Main Line Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01727531 is a NA study that has completed, run by Main Line Health. The registered enrollment target is 20 participants.
The verdict
NCT01727531, a NA study, has completed, sponsored by Main Line Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research is being done to determine if a short course of Chloroquine (five weeks) before, during and after whole brain radiation therapy (WBRT) will improve the overall survival of subjects being treated for brain metastases.
Interventions
- DRUG Chloroquine diphosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01727531
The ClinicalTrials.gov registry entry for NCT01727531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Main Line Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chloroquine diphosphate is the first listed.
NCT01727531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01727531 about?
NCT01727531 is a clinical study titled "IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy". This research is being done to determine if a short course of Chloroquine (five weeks) before, during and after whole brain radiation therapy (WBRT) will improve the overall survival of subjects being treated for brain metastases.
What is the current status of trial NCT01727531?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-12. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01727531?
The interventions under investigation include: Chloroquine diphosphate (DRUG).
Who is sponsoring clinical trial NCT01727531?
This trial is sponsored by Main Line Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.